HPTN Studies

HPTN research studies are developed by protocol teams that include CTU investigators and recognized experts in HIV prevention. As study protocols are developed, they undergo a rigorous intra- and extra-network review process that ensures compliance with current ethical guidelines and regulatory procedures.

Each Study Protocol is available once version 1.0 is approved and distributed to the performance sites. The CORE Protocol Contact can provide additional information and materials.

Recent Publications

Moore JR, Donnell DJ, Boily MC, Mitchell KM, Delany-Moretlwe S, Bekker LG, Mgodi NM, El-Sadr W, Cohen MS, Celum CL, Dimitrov D . Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression [HPTN 082]. Journal of Acquired Immune Deficiency Syndromes. 2020, 85: 423-429
Fogel JM, Bonsall D, Cummings V, Bowden R, Golubchik T, de Cesare M, Wilson EA, Gamble T, Del Rio C, Batey DS, Mayer KH, Farley JE, Hughes JP, Remien RH, Beyrer C, Fraser C, Eshleman SH . Performance of a High-Throughput Next-Generation Sequencing Method for Analysis of Hiv Drug Resistance and Viral Load. [HPTN 078]. 2020
Sandfort TG, Hamilton EL, Marais A, Guo X, Sugarman J, Chen YQ, Cummings V, Dadabhai S, Dominguez K, Panchia R, Schnabel D, Zulu F, Reynolds D, Radebe O, Mbeda C, Kamba D, Kanyemba B, Ogendo A, Stirratt M, Chege W, Lucas J, Fawzy M, McKinstry LA, Eshleman SH . The Feasibility of Recruiting and Retaining Men Who Have Sex with Men and Transgender Women in a Multinational Prospective Hiv Prevention Research Cohort Study in Sub-Saharan Africa (Hptn 075). J Int AIDS Soc. 2020, 23: e25600
Kiriazova T, Go VF, Hershow RB, Hamilton EL, Sarasvita R, Bui Q, Lancaster KE, Dumchev K, Hoffman IF, Miller WC, Latkin CA . Perspectives of Clients and Providers on Factors Influencing Opioid Agonist Treatment Uptake among Hiv-Positive People Who Use Drugs in Indonesia, Ukraine, and Vietnam: Hptn 074 Study.. 2020
Sivay MV, Palumbo PJ, Zhang Y, Cummings V, Guo X, Hamilton EL, McKinstry L, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort TGM, Eshleman SH . Hiv Drug Resistance, Phylogenetic Analysis, and Superinfection among Men Who Have Sex with Men and Transgender Women in Sub-Saharan Africa: Hptn 075. Clin Infect Dis. 2020
Topazian HM, Stoner MCD, Edwards JK, Kahn K, Gomez-Olive FX, Twine R, Hughes JP, Cohen MS, Pettifor A . Variations in Hiv Risk by Young Women's Age and Partner Age Disparity in Rural South Africa (Hptn 068).. J Acquir Immune Defic Syndr. 2020, 83: 350-356

Scholars Program

The HIV Prevention Trials Network (HPTN) is proud to offer two scholarship programs for early-career investigators funded through a supplement from the National Institute of Allergy and Infectious Diseases (NIAID). The HPTN Scholars Program now includes two components: a domestic (U.S.) program and an international program. Both programs seek to increase opportunities for scientists from groups under-represented in HIV prevention research.

In the domestic program, successful applicants will be Investigators who have received their terminal degree (MD, Phd, etc). For the international version, current MD, PhD, and MBChB students may apply, along with individuals having already graduated with their terminal degree. In both programs, applicants should desire to work with a mentor scientist in the Network to complete a research project based upon an existing HPTN research study.

Learn more about the Scholars Program